Literature DB >> 272980

Pulmonary toxicity recurring after a six week course of busulfan therapy and after subsequent therapy with uracil mustard.

D G Hankins, S Sanders, F M MacDonald, C W Drage.   

Abstract

A growing number of drugs, including a number of alkylating agents, have been implicated as the cause of pulmonary diseases. A patient with chronic myelogenous leukemia presented with typical cytology, biopsy, and roentgenologic findings of lung toxicity after only six weeks of therapy with busulfan. There was subsequent clearing. A similar roentgenologic change also occurred after administration of uracil mustard. This has not been reported previously.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 272980     DOI: 10.1378/chest.73.3.415

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  Lung damage from cytotoxic drugs.

Authors:  C H Collis
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

2.  Accelerated ovarian aging in mice by treatment of busulfan and cyclophosphamide.

Authors:  Yan Jiang; Jing Zhao; Hui-jing Qi; Xiao-lin Li; Shi-rong Zhang; Daniel W Song; Chi-yang Yu; Jian-gang Gao
Journal:  J Zhejiang Univ Sci B       Date:  2013-04       Impact factor: 3.066

Review 3.  Cancer, chemotherapy and anaesthesia.

Authors:  F Chung
Journal:  Can Anaesth Soc J       Date:  1982-07

Review 4.  Interstitial lung disease--an underdiagnosed side effect of chlorambucil?

Authors:  M Mohr; D Kingreen; H Rühl; D Huhn
Journal:  Ann Hematol       Date:  1993-12       Impact factor: 3.673

Review 5.  Busulfan-Induced Lung Injury in Pediatric Oncology Patients-Review of the Literature with an Illustrative Case.

Authors:  Nusa Matijasic; Aleksandra Bonevski; Visnja Tokic Pivac; Ivan Pavic
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2019-09-17       Impact factor: 1.349

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.